• Home
  • Search
  • Left atrial appendage closure outcomes in relation to atrial fibrillation patterns: a comprehensive analysis.
  • https://doi.org/10.3389/fcvm.2024.1389811Copy DOI Icon

Left atrial appendage closure outcomes in relation to atrial fibrillation patterns: a comprehensive analysis.

Show More
  • Abstract
  • Highlights & Summary
  • PDF
  • Literature Map
  • References
  • Similar Papers
Abstract

The effect of atrial fibrillation (AF) patterns on outcomes remains controversial. This study aims to evaluate the influence of AF type on the risk of cardiocerebrovascular events after left atrial appendage closure (LAAC) at long-term follow-up. AF was categorized as paroxysmal AF (PAF) and non-PAF (NPAF). The baseline characteristics, procedural data, peri-procedural complications, and long-term outcomes between patients with PAF and NPAF after LAAC were compared. We analyzed 410 AF patients (mean age 74.8 ± 8.2 years; 271 male; 144 with PAF, 266 NPAF). The NPAF group tended to be older (≥75 years), male, and have chronic kidney disease (CKD) compared with the PAF group. The procedural data and peri-procedural complications were comparable. During 2.2 ± 1.5 years of follow-up, the incidences of thromboembolism, major bleeding, and device-related thrombus (DRT) did not differ between the two groups. The observed risk of thromboembolism and major bleeding was significantly lower than the estimated risk based on the CHA2DS2-VASc and HAS-BLED scores, respectively, in patients who underwent LAAC, regardless of the AF type. NPAF patients were associated with a higher risk of all-cause mortality, non-cardiovascular mortality, and combined efficacy endpoints. This association disappeared after propensity score matching (PSM) analysis. The risk of thromboembolism and major bleeding was lower in patients who underwent LAAC, regardless of the AF type. Although NPAF often coexists with multiple risk factors, it was not associated with worse long-term outcomes after LAAC when compared with PAF.

Loading PDF

Similar Papers
  • Research Article

Stroke prevention with left atrial appendage closure in high-risk, non-valvular atrial fibrillation patients complicated with coronary artery disease: a single-center retrospective study

  • Aug 28, 2017
  • Chin J Cardiac Arrhyth
  • Yu-Yi Chen +5
  • Research Article
  • Citations16

Feasibility and Safety of Left Atrial Appendage Closure Using the LAmbre Device in Patients with Nonvalvular Atrial Fibrillation with or Without Prior Catheter Ablation.

  • Nov 20, 2018
  • International heart journal
  • Xiang-Fei Feng +4
  • Research Article
  • Citations1

Abstract 18131: Canadian Multi-center Experience With WATCHMAN for Percutaneous Left Atrial Appendage Closure

  • Nov 10, 2015
  • Circulation
  • Jacqueline Saw +7
  • Research Article
  • Citations6

Surgical and transcatheter left atrial appendage closure in patients with atrial fibrillation and hypertrophic cardiomyopathy.

  • May 05, 2023
  • Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
  • Tasveer Khawaja +9
  • Research Article
  • Citations5

Left atrial appendage closure for stroke prevention in atrial fibrillation: Final report from the French left atrial appendage closure registry.

  • May 29, 2021
  • Catheterization and Cardiovascular Interventions
  • Emmanuel Teiger +14
  • Research Article
  • Citations1

Incidence and predictors of device-related thrombus after left atrial appendage closure with Watchman device.

  • Jan 01, 2024
  • Postepy w kardiologii interwencyjnej = Advances in interventional cardiology
  • Jakub Maksym +9
  • Research Article
  • Citations26

Percutaneous Left Atrial Appendage Closure Is a Reasonable Option for Patients With Atrial Fibrillation at High Risk for Cerebrovascular Events.

  • Mar 01, 2018
  • Circulation: Cardiovascular Interventions
  • Emmanuel Teiger +14
  • Research Article
  • Citations101

Comparison of cardiac computed tomography angiography and transoesophageal echocardiography for device surveillance after left atrial appendage closure.

  • Oct 01, 2019
  • EuroIntervention
  • Sadia R Qamar +5
  • Research Article

Abstract 11896: Percutaneous Left Atrial Appendage Closure is Reasonable Option for the Treatment of Patients With Atrial Fibrillation at High Risk for Cerebrovascular Events

  • Nov 11, 2016
  • Circulation
  • Emmanuel Teiger +14
  • Research Article
  • Citations6

Initial experience of percutaneous left atrial appendage closure using the LAmbre device for thromboembolic prevention.

  • Sep 01, 2018
  • Journal of Cardiovascular Medicine
  • Nico Reinsch +5
  • Research Article
  • Citations1

Left atrial appendage closure in patients with hereditary hemorrhagic telangiectasia and atrial fibrillation: a prospective study and systematic review.

  • Jan 01, 2026
  • European journal of internal medicine
  • Torres-Iglesias R +13
  • Research Article
  • Citations1

Percutaneous left atrial appendage closure for thromboembolic prophylaxis in patients with atrial fibrillation. The impact of operator’s experience on the procedure course

  • Jan 29, 2016
  • Medical Research Journal
  • Dorota Kolanowska +9
  • Research Article
  • Citations44

Percutaneous WATCHMAN Left Atrial Appendage Closure for Japanese Patients With Nonvalvular Atrial Fibrillation at Increased Risk of Thromboembolism - First Results From the SALUTE Trial.

  • Oct 11, 2018
  • Circulation journal : official journal of the Japanese Circulation Society
  • Kazutaka Aonuma +11
  • Research Article

Systematic Review and Meta-Analysis of the Frequency of Thromboembolic Events, Bleeding, and Mortality in Patients with Atrial Fibrillation and End-Stage Renal Disease Undergoing Percutaneous Left Atrial Appendage Closure.

  • Mar 31, 2026
  • Journal of clinical medicine
  • Juan Manuel Martínez-Arango +4
  • Research Article

3054Efficacy and safety of non-vitamin K oral anticoagulants in patients with atrial fibrillation and cancer

  • Oct 01, 2019
  • European Heart Journal
  • Ilaria Cavallari +2
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.